These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8064498)

  • 1. Clinical report: erroneous tobramycin sampling in home intravenous therapy avoidable with modified blood draw.
    Fagerman KE
    J Intraven Nurs; 1994; 17(3):135-7. PubMed ID: 8064498
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of tobramycin levels obtained from central venous access devices in patients with cystic fibrosis is technique dependent.
    Mogayzel PJ; Pierce E; Mills J; McNeil A; Loehr K; Joplin R; McMahan S; Carson KA
    Pediatr Nurs; 2008; 34(6):464-8; quiz 468-9. PubMed ID: 19263753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regarding "antibiotic sampling" article.
    Rood T
    Pediatr Nurs; 2005; 31(1):62. PubMed ID: 15794329
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic sampling from central venous catheters versus peripheral veins.
    McBeth CL; McDonald RJ; Hodge MB
    Pediatr Nurs; 2004; 30(3):200-2. PubMed ID: 15311643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of central venous catheter and peripheral vein samples of antibiotics in children with cystic fibrosis.
    Wilson K; Jamerson PA
    J Spec Pediatr Nurs; 2013 Jan; 18(1):33-41. PubMed ID: 23289453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
    Madsen V; Lind A; Rasmussen M; Coulthard K
    J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic antibiotic serum concentrations by two blood collection methods within the pediatric patient: A comparative effectiveness trial.
    Lichliter RL; Tremewan LE; Shonka NM; Mehnert JE; Brennan L; Thrasher JM; Hernandez TL
    J Spec Pediatr Nurs; 2018 Apr; 23(2):e12212. PubMed ID: 29461683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of tobramycin levels in patients with cystic fibrosis by finger-prick sampling.
    Jones A; Beisty J; McKenna D; Clough D; Webb K; Morris J; Keevil B
    Eur Respir J; 2012 Jun; 39(6):1537-8. PubMed ID: 22654009
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of push-pull versus discard method from central venous catheters for blood testing.
    Holmes KR
    J Intraven Nurs; 1998; 21(5):282-5. PubMed ID: 9814281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
    Ritzmo C; Albertioni F; Cosic K; Söderhäll S; Eksborg S
    Ther Drug Monit; 2007 Aug; 29(4):447-51. PubMed ID: 17667799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J
    J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis.
    Touw DJ; Vinks AA; Heijerman HG; Bakker W
    Ther Drug Monit; 1993 Feb; 15(1):52-9. PubMed ID: 8451782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specimen collection. Part 6--central venous catheter tip sampling.
    Guest J
    Nurs Times; 2008 Jun 3-9; 104(22):20-1. PubMed ID: 18605629
    [No Abstract]   [Full Text] [Related]  

  • 14. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
    Edelbroek PM; van der Heijden J; Stolk LM
    Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous catheters versus peripheral veins for sampling blood levels of commonly used drugs.
    Shulman RJ; Ou C; Reed T; Gardner P
    JPEN J Parenter Enteral Nutr; 1998; 22(4):234-7. PubMed ID: 9661125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of peripheral venous access devices for obtaining blood samples for measurement of activated partial thromboplastin times.
    Prue-Owens KK
    Crit Care Nurse; 2006 Feb; 26(1):30-2, 34-8. PubMed ID: 16443808
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of infusion method on serum tobramycin concentrations in adults with cystic fibrosis.
    Pleasants RA; Williams DM; Waltner WE; Knowles MR
    Clin Pharm; 1990 Jul; 9(7):541-5. PubMed ID: 2376111
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of tobramycin and gentamicin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
    Spencer H; Kozlowska W; Davies JC; Webber P; Chadwick M; Kerr J; Makhecha S
    J Cyst Fibros; 2005 Sep; 4(3):209. PubMed ID: 15994133
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods.
    Dopfer R; Brand P; Müllinger B; Hunger T; Häussermann S; Meyer T; Scheuch G; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):141-54. PubMed ID: 18204125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.